Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Operating Expenses (2021 - 2026)

HeartSciences filings provide 6 years of Operating Expenses readings, the most recent being $1.9 million for Q1 2026.

  • On a quarterly basis, Operating Expenses fell 18.66% to $1.9 million in Q1 2026 year-over-year; TTM through Jan 2026 was $7.8 million, a 6.14% decrease, with the full-year FY2025 number at $8.4 million, up 32.24% from a year prior.
  • Operating Expenses hit $1.9 million in Q1 2026 for HeartSciences, down from $2.1 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $2.4 million in Q1 2025 to a low of $1.1 million in Q1 2022.
  • Median Operating Expenses over the past 5 years was $1.9 million (2025), compared with a mean of $1.8 million.
  • Biggest five-year swings in Operating Expenses: skyrocketed 111.67% in 2022 and later dropped 19.29% in 2023.
  • HeartSciences' Operating Expenses stood at $1.8 million in 2022, then decreased by 11.41% to $1.6 million in 2023, then increased by 26.25% to $2.0 million in 2024, then rose by 4.52% to $2.1 million in 2025, then dropped by 7.03% to $1.9 million in 2026.
  • The last three reported values for Operating Expenses were $1.9 million (Q1 2026), $2.1 million (Q4 2025), and $1.9 million (Q3 2025) per Business Quant data.